Lion Point Capital, LP - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Lion Point Capital, LP held in its portfolio 39 assets valued at $19,323,534 (i.e. $19.32M).

The most valuable assets in the portfolio included: MILESTONE PHARMACEUTICALS IN ($1.53M), PRAXIS PRECISION MEDICINES I ($1.31M), and MOONLAKE IMMUNOTHERAPEUTICS ($889.65K).

The chart below shows the top 10 valuable assets, and the table below shows the top 39 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.
Data Source: SEC.
Top Valuable Stocks in Lion Point Capital, LP Portfolio
MILESTONE PHARMACEUTICALS IN
PRAXIS PRECISION MEDICINES I
MOONLAKE IMMUNOTHERAPEUTICS
FENNEC PHARMACEUTICALS INC
JASPER THERAPEUTICS INC
BENITEC BIOPHARMA INC
ROYALTY PHARMA PLC
GERON CORP
SYNDAX PHARMACEUTICALS INC
ARDELYX INC
Lion Point Capital, LP - Stock Holdings in 13F Filings (SEC)
Items per page:
0 of 0
Name of Issuer No. of Shares Value ($) Class
MILESTONE PHARMACEUTICALS IN 755000 1525100 COM
PRAXIS PRECISION MEDICINES I 4450 1311593 COM NEW
MOONLAKE IMMUNOTHERAPEUTICS 67500 889650 CLASS A ORD
FENNEC PHARMACEUTICALS INC 112434 865742 COM
JASPER THERAPEUTICS INC 465000 850950 COM NEW
BENITEC BIOPHARMA INC 62000 835140 COM NEW
ROYALTY PHARMA PLC 21400 826896 SHS CLASS A
GERON CORP 578000 762960 COM
SYNDAX PHARMACEUTICALS INC 36000 756360 COM
ARDELYX INC 128650 750030 COM
CUE BIOPHARMA INC 2202854 672752 COM
DISC MEDICINE INC 8100 643221 COM
SAREPTA THERAPEUTICS INC 28500 613320 COM
BIOHAVEN LTD 51700 583693 COM
HUMACYTE INC 500000 480250 COM
KURA ONCOLOGY INC 46000 477940 COM
SERES THERAPEUTICS INC 31570 469762 COM NEW
COMPASS PATHWAYS PLC 58000 400200 SPONSORED ADS
DAY ONE BIOPHARMACEUTICALS I 42000 391440 COM
REGENXBIO INC 26600 383040 COM
BRIDGEBIO PHARMA INC 5000 382450 COM
MINERALYS THERAPEUTICS INC 10500 381045 COM
VENTYX BIOSCIENCES INC 41500 374745 COM
LANTHEUS HLDGS INC 5500 366025 COM
DYNE THERAPEUTICS INC 18000 352080 COM
UNIQURE NV 14700 351771 SHS
PACIRA PHARMACEUTICALS INC 13500 349380 COM
VIATRIS INC 27700 344865 COM
AZENTA INC 9700 322622 COM
ROCKET PHARMACEUTICALS INC 86000 301860 COM
JANUX THERAPEUTICS INC 19000 262200 COM
EDGEWISE THERAPEUTICS INC 9100 225817 COM
INNOVIVA INC 8200 163918 COM
ARCUTIS BIOTHERAPEUTICS INC 5250 152460 COM
INNATE PHARMA S A 81151 142014 SPONSORED ADS
MINERVA NEUROSCIENCES INC 35000 140700 COM NEW
GH RESEARCH PLC 10200 129540 ORDINARY SHARES
SPRUCE BIOSCIENCES INC 1000 87110 COM NEW
MERSANA THERAPEUTICS INC 100 2893 COM